Advances in Pharmacological and Pharmaceutical Sciences / 2016 / Article / Tab 2

Research Article

Development of an Experimental Model of Diabetes Co-Existing with Metabolic Syndrome in Rats

Table 2

Metabolic parameters in the experimental groups.

SNVariable NCHF-DC

1TG (mg/dL)63.75 ± 11.47312.85 ± 62.24
2HDL (mg/dL)32.62 ± 2.5626.57 ± 5.74
3LDL (mg/dL)12.6 ± 2.4162.57 ± 12.44
4HbA1c (%)6.22 ± 0.4312.78 ± 1.50
5Insulin (µU/mL)6.46 ± 0.652.94 ± 1.11
6C-Peptide (ng/mL)0.07 ± 0.020.05 ± 0.035
7HOMA-IR 1.57 ± 0.162.17 ± 0.63
8HOMA-β66.6 ± 5.865.9 ± 1.2
9Atherogenic index1.36 ± 0.2011.34 ± 5.01

NC: Normal Control group (); HF-DC: High Fat Diabetic Control group (). Values are expressed as mean ± SD. , , NC versus HF-DC.